Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
OSE Immunotherapeutics
company
About
OSE Immunotherapeutics is a clinical-stage biotechnology company focused on developing.
- 51 - 100
Highlights
Details
- Last Funding Type
- Debt Financing
- Last Funding Money Raised
- €10M
- Industries
- Biotechnology,Medical,Medical Device,Pharmaceutical
- Founded date
- Jan 1, 2012
- Number Of Employee
- 51 - 100
- Operating Status
- Active
OSE Immunotherapeutics is a biotechnology company led by world-class immunologists and focused on the development of innovative immunotherapies for immune activation and regulation in the fields of immuno-oncology, auto-immune diseases and transplantation.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
€10M
OSE Immunotherapeutics has raised a total of
€10M
in funding over 2 rounds. Their latest funding was raised on
Jul 9, 2021 from a Debt Financing round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jul 9, 2021 | Debt Financing | €10M | 1 |
European Investment Bank
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
OSE Immunotherapeutics is funded by 1 investors.
European Investment Bank
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
European Investment Bank
|
Yes | Debt Financing |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
